Walensky Flip-Flops: Says CDC Not Examining Changing Definition Of "Fully Vaccinated" Authored by Zachary Stieber via The Epoch Times, The Centers for Disease Control and Prevention...
Groundbreaking Israeli Study Shows How COVID Proteins Attack The Heart And Blood Vessels Earlier Thursday morning, we shared a report about a strange phenomenon unfolding at...
Infectious disease experts from both West Virginia University and Marshall University will team up to identify and track SARS-CoV-2 variants circulating in West Virginia in hopes of preparing...
Nearly two years since becoming a global pandemic that has killed millions of people, the mystery of which proteins in the SARS-CoV-2 virus are responsible for...
Cambridge, Mass.-based Moderna and Emeryville, Calif.-based Metagenomi inked a strategic research and development deal on new gene editing systems for in vivo (in the body) human therapies.
Moderna has always been thinking about how mRNA could transform the gene editing space, according to Eric Huang. In fact, they looked at it about a...
Biotech stocks to note as the coronavirus pandemic rages on across the globe. The post Best Biotech Stocks To Buy Now? 5 To Check Out In...
In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the...
A recent MarketsandMarkets report details the key drivers and identifies the prominent players in the fast-growing field of synthetic biology. The post Overview of the Synthetic...
In emulation of computer science, synthetic biology is using “integrated circuits” and “logic boards” to speed the development of powerful therapeutic applications. The post Synthetic Biology...
'I Had To Stand Up And Try To Do Something:' Professor Of Medicine On Suing School Over Vaccine Mandate Authored by Jan Jekielek and Zachary Stieber...
John Maraganore The departure of a number of CEOs is the prevailing theme that kicks off this week’s installment: In a stunner, Alnylam CEO John Maraganore...
From the Florida Keys to the Caribbean Sea, coral reefs, the complex ecosystems that house 25% of marine species, are dying from a novel infection known...
These 4 biotech stocks are gaining momentum this week. The post Cheap Stocks To Buy Now? 4 Biotech Stocks For Your Watchlist appeared first on Stock...
Mammoth and Vertex plan to apply Mammoth’s CRISPR platform consisting of a proprietary toolbox of novel Cas enzymes—what the company calls the largest toolbox of CRISPR...
UV lights come in a variety of different wavelengths, but not all are equally effective at disinfection. Researchers tested a number of commercially available lights to...
CRISPR-edited therapies have been an area of focus for Vertex. Late last year, the company and CRISPR Therapeutics reported positive data from a pair of Phase I/II...
David Lockhart did not see the meteoric rise of messenger RNA and lipid nanoparticles coming. Thanks to the worldwide fight against Covid-19, mRNA — the genetic...
When I wrote about SARS-CoV-2 variants in the March edition of my column, no one could say with certainty how new variants of SARS-CoV-2 would change...
Bolstering the latest advances and opportunities in RNA The post RNA Therapeutics 2022 appeared first on .
There is immense interest in understanding whether potentially protective SARS-CoV-2 antibodies are provided to the baby via breast milk. This is what we know so far.
Dem Lawmakers Demand Moderna Share Vaccine Recipe To "Expand Global Access" During an interview with the AP last week, Moderna Chairman Noubar Afeyan reaffirmed that Moderna...
Goldman Picks Winners And Losers In Battle For $20 Billion COVID Antiviral Market Ten days have passed since Merck dropped its bombshell announcement about Molnupiravir, its...
Merck To Double Production Of 'Breakthrough' COVID Drug As Nations Line Up To Buy Despite safety concerns raised by multiple scientists, Merck is signing deals with...
Media Now Claims That "Double Jabbed" Brits Who Have Bad Colds Are Actually Suffering From COVID Authored by Paul Joseph Watson via Summit News, Causing yet...
Recent computer modeling shows the upcoming flu season might see a surge in cases. Coupled with COVID-19’s continued threat, doctors are again urging Americans to get...
Shares of Vaxart Inc. (VXRT) rose 8.74%, at the time of writing, in early trade on Friday. The stock price moved after a Duke University-led study...
David Grainger → In a development that just seemed to add up neatly given Medicxi’s involvement with Centessa, the brainchild of Francesco de Rubertis has named...
Navy SEALs Lawyer: Military Ignoring Natural Immunity Authored by Zachary Stieber and Joshua Philipp via The Epoch Times, A U.S. Navy service member is seen getting...
WHO-Linked Genetics Expert Explains How Covid-19 Could Have Been Engineered In Lab Two weeks ago we reported on several disturbing grant proposals submitted to the US...